Pharma Faces / Taher Hassen, Merck Morocco
Taher Hassen has been in position as GM for Morocco and Tunisia at Merck for four years, overseeing year-on-year…
MIDDLE EAST & AFRICA
The Long Read / The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat…
MEA / Medtronic: Taking Tech to Emerging Markets
Global medtech giant Medtronic manages a highly diverse region that spans both developed and developing markets…
Morocco Local Production Snapshot
A new IQVIA study sponsored by LEMM, the Moroccan association of multinationals looked at 3,437 references sold on…
Download / New UAE Pharma Report April 2020 Out Now
PharmaBoardroom’s latest country report gives an up-to-date and comprehensive overview of one of the most…
Opinion / Malaria Prevention Cannot be Allowed to Stall During the COVID-19 Pandemic
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr…
Medtech / Strategies in Saudi Arabia
Saudi Arabia is seeing an increased demand for more innovative medical devices and a greater awareness of the…
Data / Top 10 Pharma Companies in Saudi Arabia 2019
The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10…
South Africa / Aspen Inks Deal to Manufacture J&J’s COVID-19 Vaccine
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…
In Conversation
Pierre Behnam – General Manager, Pierre Fabre Morocco
Pierre Behnam, general manager of Pierre Fabre in Morocco, breaks down the strong and long-standing footprint of the group in the country in the medical and dermo-cosmetic fields. On the medical side, he talks about the amazing progress Morocco has made in the prevention and treatment of cancer, and his ambition to bring Pierre Fabre’s innovative targeted therapies and adjuvant…
Latest Reports
Focus on UAE
The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the…
New UAE Pharma Report April 2020 Out Now
PharmaBoardroom's latest country report gives an up-to-date and comprehensive…
Read more from UAE >>
Focus on Morocco
Morocco: Standing Firm
Valued by Fitch at a trifling USD 1.6 billion, the Moroccan pharma sector can be…
Oncology in Morocco: Access Challenges & New Solutions
Morocco has made admirable progress in building a national oncology network in…
Read more from Morocco >>
Focus on Turkey
Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in…
Acıbadem’s Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more…
Read more from Turkey >>
Focus on Egypt
Striking the Access/Innovation Balance in Egyptian…
As Egypt rolls out Universal Health Insurance with the aim of achieving full…
GE Healthcare Egypt: Reimagining Care Provision
Amro Kandil, managing director Northeast Africa for GE Healthcare, outlines how…
Read more from Egypt >>
COVID-19 / Cipla to Begin Manufacturing Remdesivir in South Africa
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
MEA / Gulf Healthcare Costs to Rise Drastically in 2020
Growing incidence of lifestyle-related diseases, coupled with high drug prices, are driving up healthcare costs at…
Financing Egypt’s new Universal Health Insurance
After months of discussion, in December 2017 Egypt’s Parliament approved a new national health insurance law that…
NEW Special Pharma Report on Algeria
Click here to download the Healthcare & Life Sciences Review Algeria 2019 report. Algeria, Africa’s…
Rankings / Top 10 Pharma Companies in Saudi Arabia
The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10…
Opinion / The Case for an Algerian FDA in the Wake of Unethical TV Ads
In the wake of a spate of television advertisements for dietary supplements claiming to offer solutions to the…